Natural history, epidemiology, and prognosis of aortic stenosis
- William H Gaasch, MD
William H Gaasch, MD
- Section Editor — Valvular Disease
- Professor of Medicine
- University of Massachusetts Medical School
- Tufts University School of Medicine
- Senior Consultant in Cardiology
- Lahey Clinic
Aortic valve stenosis (AS, aortic stenosis) is the most common cause of left ventricular outflow obstruction in children and adults; less common causes are subvalvular or supravalvular disease (table 1).
The epidemiology and natural history of AS will be reviewed here. The clinical features, diagnosis, evaluation, medical therapy, percutaneous aortic valvotomy, transcatheter aortic valve replacement, and surgical aortic valve replacement for AS are discussed separately. (See "Clinical manifestations and diagnosis of aortic stenosis in adults" and "Medical management of asymptomatic aortic stenosis in adults" and "Indications for valve replacement in aortic stenosis in adults".)
Aortic valve sclerosis is defined as aortic valve thickening and calcification without a significant gradient (defined as an aortic jet velocity <2 m/sec). Aortic stenosis (AS) is present when the antegrade velocity across an abnormal valve is at least 2 m/sec. The stages of AS are defined by symptoms, valve anatomy, valve hemodynamics, and left ventricular function (table 2). (See "Aortic valve sclerosis and pathogenesis of calcific aortic stenosis" and "Clinical manifestations and diagnosis of aortic stenosis in adults" and "Echocardiographic evaluation of the aortic valve".)
Severe AS is defined as AS with a maximum aortic transvalvular velocity ≥4 m/s with typically an aortic valve area ≤1 cm2. Very severe AS is present when the Doppler aortic jet velocity is ≥5 m/sec (table 3). (See "Aortic valve area in aortic stenosis", section on 'Critical valve area and severity'.)
The term “symptomatic AS” refers to AS that is causing cardiac symptoms. End-stage symptoms include heart failure, anginal chest discomfort, and syncope. However, the most common symptoms in patients who are followed prospectively are decreased exercise tolerance, or dyspnea on exertion. (See "Clinical manifestations and diagnosis of aortic stenosis in adults", section on 'Symptoms'.)To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart 2013; 99:396.
- Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920.
- Jin XY, Pepper JR, Gibson DG. Effects of incoordination on left ventricular force-velocity relation in aortic stenosis. Heart 1996; 76:495.
- Cheitlin MD, Gertz EW, Brundage BH, et al. Rate of progression of severity of valvular aortic stenosis in the adult. Am Heart J 1979; 98:689.
- Wagner S, Selzer A. Patterns of progression of aortic stenosis: a longitudinal hemodynamic study. Circulation 1982; 65:709.
- Cha SD, Naeem SM, Maranhao V, Gooch AS. Sequential study of left ventricular function in aortic valvular stenosis. Cathet Cardiovasc Diagn 1982; 8:145.
- Jonasson R, Jonsson B, Nordlander R, et al. Rate of progression of severity of valvular aortic stenosis. Acta Med Scand 1983; 213:51.
- Nestico PF, DePace NL, Kimbiris D, et al. Progression of isolated aortic stenosis: analysis of 29 patients having more than 1 cardiac catheterization. Am J Cardiol 1983; 52:1054.
- Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987; 8:471.
- Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 1991; 12:10.
- Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:2262.
- Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am Heart J 1996; 132:408.
- Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611.
- Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000; 101:2497.
- Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989; 13:545.
- Roger VL, Tajik AJ, Bailey KR, et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 1990; 119:331.
- Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992; 70:229.
- Peter M, Hoffmann A, Parker C, et al. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest 1993; 103:1715.
- Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol 1995; 25:305.
- Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111:3290.
- Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121:151.
- Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111:3316.
- Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006; 47:2229.
- Bahler RC, Desser DR, Finkelhor RS, et al. Factors leading to progression of valvular aortic stenosis. Am J Cardiol 1999; 84:1044.
- Pohle K, Mäffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104:1927.
- Kamalesh M, Ng C, El Masry H, et al. Does diabetes accelerate progression of calcific aortic stenosis? Eur J Echocardiogr 2009; 10:723.
- Garcia D, Pibarot P, Dumesnil JG, et al. Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 2000; 101:765.
- Lester SJ, McElhinney DB, Miller JP, et al. Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis. Circulation 2000; 101:1947.
- Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980; 99:419.
- Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38:61.
- Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982; 66:1105.
- Kitai T, Honda S, Okada Y, et al. Clinical outcomes in non-surgically managed patients with very severe versus severe aortic stenosis. Heart 2011; 97:2029.
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597.
- Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010; 122:S37.
- Faggiano P, Antonini-Canterin F, Ribichini F, et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 2000; 85:204.
- ETIOLOGY OF AORTIC STENOSIS
- PROGRESSION OF AORTIC STENOSIS
- Observational studies
- - Overview
- - University of Washington
- - Medical University of Vienna
- - Mayo Clinic
- Risk factors for progression
- - Effect of cause of AS
- PROGNOSIS OF SYMPTOMATIC AS
- Pulmonary hypertension
- INFORMATION FOR PATIENTS